Skip to content

Clinical trials

Hyperparathyroidism, Secondary trials with unknown status

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hyperparathyroidism, Secondary Status: Unknown status Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20101
20111
20121
20155
20171
20202
20221
20231
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status16

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University of Sao Paulo General Hospital2
Azienda Ospedaliera Sant'Anna1
Beijing Friendship Hospital1
Chengdu Suncadia Medicine Co., Ltd.1
Chunling Jiang1
ENRICO VERRINA1
GAAD Medical Research Institute Inc.1
Hospices Civils de Lyon1
Iain Bressendorff1
Limeng Chen1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hyperparathyroidism, Secondary16
Renal Insufficiency, Chronic5
Chronic Kidney Disease-Mineral and Bone Disorder2
Hyperparathyroidism2
Hyperparathyroidism, Primary2
Hypocalcemia2
Anemia1
Hyperphosphatemia1
Hypoparathyroidism1
Kidney Failure, Chronic1

Trials

Showing 26 to 16 of 16. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.